The anti-amyloid approach to treating Alzheimer's disease is seeing new life after Eisai and Biogen announced that lecanemab slowed progression of disease in a Phase III study. | Continue reading
1E Therapeutics announced $120 million seed funding, a remarkable feat for an early-stage biotech company. The funding is the largest of its kind for an Israeli biotech company. | Continue reading
The FDA's IND approval sets the stage for the very first Phase I/II trial to evaluate EBT-101 as a functional cure for chronic HIV based on the endpoints of safety, tolerability, and efficacy. | Continue reading
Retinal tissue has been regrown in three patients with age-related macular degeneration with geographic atrophy or dry (atrophic) AMD in a Phase I/IIa study conducted by Lineage Cell Therapeutics. | Continue reading
Preliminary data from Annovis Bio’s Phase II study of ANVS401 shows significant cognitive improvements in Alzheimer’s patients after only one month of treatment. | Continue reading
Bristol Myers picked up the therapy when it acquired Celgene in 2019 for $74 billion. | Continue reading
There are over 170 COVID-19 vaccine candidates at various stages of development, and all but a few of them take the traditional intramuscular approach. But could intranasal delivery ease the logistical nightmare we face in exterminating the pandemic across the globe? | Continue reading
Phase I data from the COVID-19 vaccine under development by AstraZeneca and Oxford University’s Jenner Institute is showing a robust defense against the novel coronavirus that has infected more than 13 million people across the globe. | Continue reading
The company announced that one of its antibodies, STI-1499, has shown 100% inhibition of SARS-CoV-2 in laboratory tests. | Continue reading
Researchers at Switzerland-based Empa, ETH Zurich and Zurich University Hospital have developed a sensor that has the potential to identify SARS-CoV-2, the novel coronavirus that causes COVID-19, in the air. | Continue reading
20/20 BioResponse to Launch Rapid Coronavirus Test Kits in U.S. following “Green Light” from FDA - read this article along with other careers information, tips and advice on BioSpace | Continue reading
Inside the U.S., the first clinical trial for a vaccine to the novel coronavirus that causes COVID-19 begins today. | Continue reading
Researchers revolutionize 3D bioprinting by engineering working components of the human heart - read this article along with other careers information, tips and advice on BioSpace | Continue reading
Dewpoint Therapeutics Launches with $60 Million Series A to Advance Proprietary Platform for Drugging Condensates - read this article along with other careers information, tips and advice on BioSpace | Continue reading
Turning an existing partner into a wholly owned subsidiary, Novartis is acquiring CellforCure from biotechnology group LFB for an undisclosed figure. | Continue reading
New research is shedding some light on how the brain responds when people are feeling sad, which could lead to new methods of treating some mood disorders. A research team from the University of California, San Francisco (UCSF) reported in an article in Cell that a network define … | Continue reading
Researchers from Amen Clinics in Costa Mesa, California, Google, John’s Hopkins University, University of California, Los Angeles and the University of California, San Francisco studied 62,454 brain scans of more than 30,000 people to study brain aging. | Continue reading